scispace - formally typeset
M

Matteo Cassina

Researcher at University of Padua

Publications -  75
Citations -  2958

Matteo Cassina is an academic researcher from University of Padua. The author has contributed to research in topics: Pregnancy & Gene. The author has an hindex of 21, co-authored 66 publications receiving 1900 citations. Previous affiliations of Matteo Cassina include University of Utah.

Papers
More filters
Journal ArticleDOI

Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

Phil Lee, +606 more
- 12 Dec 2019 - 
TL;DR: Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting substantial pleiotropy of contributing loci within genes that show heightened expression in the brain throughout the lifespan, beginning prenatally in the second trimester, and play prominent roles in neurodevelopmental processes.
Journal ArticleDOI

Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa

Hunna J. Watson, +258 more
- 01 Aug 2019 - 
TL;DR: The genetic architecture of anorexia nervosa mirrors its clinical presentation, showing significant genetic correlations with psychiatric disorders, physical activity, and metabolic (including glycemic), lipid and anthropometric traits, independent of the effects of common variants associated with body-mass index.
Journal ArticleDOI

Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa

Hunna J. Watson, +209 more
Journal ArticleDOI

Treatment of Hyperthyroidism in Pregnancy and Birth Defects

TL;DR: In this paper, the authors examined the association of both drugs with congenital malformations using data from the International Clearinghouse for Birth Defects Surveillance and Research (ICSBRS).
Journal ArticleDOI

First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis

TL;DR: There is currently no evidence that metformin is associated with an increased risk of major birth defects in women affected by PCOS and treated during the first trimester, but larger ad hoc studies are warranted in order to definitely confirm the safety and efficacy of this drug in pregnancy.